Summary
Goodwin Procter's Life Sciences Practice will host its annual reception in conjunction with the JP Morgan Healthcare Conference in San Francisco, CA. The reception is expected to draw nearly 500 life sciences industry executives and investors.
Related Content
- Life Sciences PerspectivesSeptember 15, 2023
Modernizing the FDA’s 510(k) Program for Medical Devices: Selection of Predicate Devices and Use of Clinical Data in 510(k) Submissions
- Big Molecule WatchSeptember 15, 2023
Generic and Biosimilar Drugs Save $408B For America’s Patients and Healthcare System in 2022
- Life Sciences PerspectivesSeptember 15, 2023
UK’s Medicines Regulator Announces Guidance on the New International Recognition Procedure for the Approval of New Medicines from 1 January 2024
- AlertSeptember 15, 2023
Modernizing the FDA’s 510(k) Program for Medical Devices: Selection of Predicate Devices and Use of Clinical Data in 510(k) Submissions
- Big Molecule WatchSeptember 14, 2023
Legal Challenges to the Inflation Reduction Act: An Update on Pending Challenges and Reactions to Oral Argument in Dayton Area Chamber Of Commerce et al. v. Becerra et al.
- Life Sciences PerspectivesSeptember 14, 2023
PropSci Perspectives: Breakthrough Properties
- AlertSeptember 14, 2023
Sunset on (some) Stamp Taxes: HMRC confirms 1.5% charge on issuance and capital raising transfers to depositary receipt and clearance systems will not apply
- Big Molecule WatchSeptember 13, 2023
Sandoz Receives FDA Approval for TYRUKO® (natalizumab-sztn), the First and Only FDA-Approved Biosimilar for Relapsing Forms of Multiple Sclerosis
- WebinarSeptember 19, 2023
Legal Challenges to the Inflation Reduction Act: An Update on Pending Challenges and Reactions to Oral Argument in Dayton Area Chamber Of Commerce et al. v. Becerra et al.
- Press ReleaseSeptember 14, 2023
Generate:Biomedicines Completes $273 Million Series C
- Press ReleaseSeptember 13, 2023
Lauxera Capital Partners Invests €17 Million in BioLamina
- Press ReleaseSeptember 11, 2023
Magenta Therapeutics Completes Merger With Dianthus Therapeutics
- In the PressSeptember 11, 2023
Andreessen Horowitz-Backed Startup Health IQ Files For Bankruptcy (Forbes)
- Press ReleaseSeptember 8, 2023
Seagen and Nurix Enter Into Strategic Collaboration for $60 Million Upfront and up to $3.4 Billion in Milestones to Develop New Class of Cancer Drugs
- Awards and RankingsSeptember 8, 2023
Goodwin Lawyers and Practices Honored at the LMG Life Sciences Americas Awards 2023
- In the PressSeptember 7, 2023
Goodwin Secures New Philadelphia Lease, Marking Its Permanent Entry Into the City (Law.com)